Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas

Abstract

This practice recommendation presents a pragmatic framework and consensus-based mitigation strategies for the treatment of HGG patients during the SARS-CoV-2 pandemic.